Rhythm Biosciences Ltd. (AU:RHY) has released an update.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Rhythm Biosciences Ltd, a pioneer in cancer diagnostics, has announced significant changes to its board, including the retirement of long-serving directors Dr. Trevor Lockett and Mr. Lou Panaccio. Additionally, Susan MacLeman will transition from Deputy Chair to Non-Executive Director, while Gavin Fox-Smith joins as a new Independent, Non-Executive Director. These changes are aimed at optimizing the board’s structure as the company continues its mission to develop affordable, early cancer detection solutions.
For further insights into AU:RHY stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Will Palantir Stock Crash to $28? Jefferies Sounds the Alarm
- ‘Don’t Dive in Just Yet,’ Says RBC About Lucid Stock
- Another Paramount+ (NASDAQ:PARA) Price Hike in Europe
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
